These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 38950639)
1. Selected phytocannabinoids inhibit SN-38- and cytokine-evoked increases in epithelial permeability and improve intestinal barrier function in vitro. Marsh DT; Smid SD Toxicol In Vitro; 2024 Aug; 99():105888. PubMed ID: 38950639 [TBL] [Abstract][Full Text] [Related]
2. The semi-synthetic flavonoid 2',3',4'-trihydroxyflavone (2-D08) inhibits both SN-38- and cytokine-evoked increases in epithelial barrier permeability in an Marsh DT; Smid SD Food Funct; 2022 Oct; 13(21):11142-11152. PubMed ID: 36205567 [TBL] [Abstract][Full Text] [Related]
3. Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability. Alhamoruni A; Wright KL; Larvin M; O'Sullivan SE Br J Pharmacol; 2012 Apr; 165(8):2598-610. PubMed ID: 21745190 [TBL] [Abstract][Full Text] [Related]
4. Phytocannabinoids regulate inflammation in IL-1β-stimulated human gingival fibroblasts. Abidi AH; Abhyankar V; Alghamdi SS; Tipton DA; Dabbous M J Periodontal Res; 2022 Dec; 57(6):1127-1138. PubMed ID: 36070347 [TBL] [Abstract][Full Text] [Related]
5. Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model. Harvey BS; Sia TC; Wattchow DA; Smid SD Cytokine; 2014 Feb; 65(2):236-44. PubMed ID: 24238999 [TBL] [Abstract][Full Text] [Related]
6. The structurally diverse phytocannabinoids cannabichromene, cannabigerol and cannabinol significantly inhibit amyloid β-evoked neurotoxicity and changes in cell morphology in PC12 cells. Marsh DT; Sugiyama A; Imai Y; Kato R; Smid SD Basic Clin Pharmacol Toxicol; 2024 Mar; 134(3):293-309. PubMed ID: 37697481 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic control of skin differentiation genes by phytocannabinoids. Pucci M; Rapino C; Di Francesco A; Dainese E; D'Addario C; Maccarrone M Br J Pharmacol; 2013 Oct; 170(3):581-91. PubMed ID: 23869687 [TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis. Petrosino S; Verde R; Vaia M; Allarà M; Iuvone T; Di Marzo V J Pharmacol Exp Ther; 2018 Jun; 365(3):652-663. PubMed ID: 29632236 [TBL] [Abstract][Full Text] [Related]
10. Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment. Oláh A; Markovics A; Szabó-Papp J; Szabó PT; Stott C; Zouboulis CC; Bíró T Exp Dermatol; 2016 Sep; 25(9):701-7. PubMed ID: 27094344 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563 [TBL] [Abstract][Full Text] [Related]
12. Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability. Harvey BS; Nicotra LL; Vu M; Smid SD Cytokine; 2013 Aug; 63(2):209-17. PubMed ID: 23706402 [TBL] [Abstract][Full Text] [Related]
13. Comparative assessment of antimicrobial, antiradical and cytotoxic activities of cannabidiol and its propyl analogue cannabidivarin. Russo C; Lavorgna M; Nugnes R; Orlo E; Isidori M Sci Rep; 2021 Nov; 11(1):22494. PubMed ID: 34795379 [TBL] [Abstract][Full Text] [Related]
15. IL-1beta causes an increase in intestinal epithelial tight junction permeability. Al-Sadi RM; Ma TY J Immunol; 2007 Apr; 178(7):4641-9. PubMed ID: 17372023 [TBL] [Abstract][Full Text] [Related]
16. Effects of pro-inflammatory cytokines, lipopolysaccharide and COX-2 mediators on human colonic neuromuscular function and epithelial permeability. Safdari BK; Sia TC; Wattchow DA; Smid SD Cytokine; 2016 Jul; 83():231-238. PubMed ID: 27177092 [TBL] [Abstract][Full Text] [Related]
17. Effects of Cannabinoids on Intestinal Motility, Barrier Permeability, and Therapeutic Potential in Gastrointestinal Diseases. Crowley K; Kiraga Ł; Miszczuk E; Skiba S; Banach J; Latek U; Mendel M; Chłopecka M Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928387 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of combined therapy with fish oil and phytocannabinoids in murine intestinal inflammation. Pagano E; Iannotti FA; Piscitelli F; Romano B; Lucariello G; Venneri T; Di Marzo V; Izzo AA; Borrelli F Phytother Res; 2021 Jan; 35(1):517-529. PubMed ID: 32996187 [TBL] [Abstract][Full Text] [Related]
19. Modulation of Redox and Inflammatory Signaling in Human Skin Cells Using Phytocannabinoids Applied after UVA Irradiation: In Vitro Studies. Wroński A; Jarocka-Karpowicz I; Surażyński A; Gęgotek A; Zarkovic N; Skrzydlewska E Cells; 2024 Jun; 13(11):. PubMed ID: 38891097 [TBL] [Abstract][Full Text] [Related]
20. Novel Synthesis of C-Methylated Phytocannabinoids Bearing Anti-inflammatory Properties. Lavi Y; Kogan NM; Topping LM; Liu C; McCann FE; Williams RO; Breuer A; Yekhtin Z; Ezra AF; Gallily R; Feldmann M; Mechoulam R J Med Chem; 2023 Apr; 66(8):5536-5549. PubMed ID: 37057997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]